Supplement Stack and Biomarkers: Reading the Trends

In my own tracking I noticed: after two years of biohacking I had accumulated nine products and could not say whether anything attributable showed up in my lab values for any of them. The moment everything clicked was when I set up an overview board for the first time and tried to assign a measurable lab value to each product. For three of them, I simply could not think of one. Suddenly it was obvious why my tracking had never led to decisions: I had been collecting products without formulating a question about them. I then took those three products out of my routine, my monthly costs dropped from 147 to 89 euros, and my values did not get worse. This is a personal observation and not a recommendation: whether a product is taken or stopped belongs in a conversation with a doctor.

TL;DR

A supplement stack can only be put into context if lab values are documented as a trend. The Audit, Test and Scale scheme divides data collection into three stages: Audit (record the starting value and measurement conditions), Test (document accompanying factors and complaints) and Scale (compare the follow-up measurement with the starting point). The evidence on many supplements is limited or inconsistent. Whether a value changed because of a product cannot be proven from personal data alone.

This article is purely informational and does not replace medical advice. Intake, the dose set by a doctor and therapy should be clarified with a doctor, especially with chronic conditions or when taking medication.

Why an Unstructured Stack Is Hard to Evaluate

A stack without a fixed overview grows slowly but steadily. Every new podcast, every new study, every recommendation from a friend adds another product. After 12 months, 15 bottles sit on the kitchen counter and nobody remembers what they were for. Two situations show where evaluation hits its limits.

Situation 1: Twelve products, no attribution. Jonas, 34, has been biohacking for two years. His stack covers twelve different products, including vitamins, minerals and plant extracts. Monthly cost: 128 euros. When his partner asks which product is for what, all he can say is “together they keep me fit.” In reality, he has never measured a single biomarker. With twelve parallel products, attribution is impossible: any new change could come from any of the twelve, from diet, or from something else entirely.

Situation 2: Feeling versus lab value. Lena, 29, has a starting hsCRP of 1.8 mg/L and takes an omega-3 product. She “feels nothing”: no mood shift, no better skin, no faster recovery. She concludes the product does nothing. The example shows a basic problem: an inflammation marker like hsCRP cannot be felt, only measured. And even a follow-up measurement does not answer whether a change came from the product, an infection, diet or chance.

The pattern is always similar: without clear documentation, gut feeling decides, and gut feeling is an unreliable guide with supplements because many possible effects sit below the perception threshold. What helps is a fixed system with measurement points, reference values and interpretation by a doctor.

Lab Values as a Starting Point for the Conversation with a Doctor

Before a trend can be evaluated, a clean starting measurement is needed. Every entry in an overview refers to a measurable lab value, not the other way around. The Supplement Beginners Guide puts common basic supplements into context in an informational way.

Typical examples: a ferritin of 22 ng/ml, a 25-OH-D of 18 ng/ml or an hsCRP that stays above 2 mg/L are reasons for a conversation with a doctor. Whether a value is abnormal depends on the lab’s reference range, age, sex and pre-existing conditions. Whether and how to respond is decided by a doctor. Without a starting measurement there is no basis for comparison.

The Biomarker Baseline Checklist describes how to build a clean starting measurement in 48 hours that later measurements are compared against. Without a baseline, any look back is of little value.

The 3 Phases of Data Collection: Audit, Test, Scale

The scheme divides observation into three stages in a fixed order. It describes data collection and interpretation, not the use of products.

Audit (Starting Point)

In the Audit phase, each lab value is recorded with what is measured and which reference value (the lab’s reference range) it is compared against. The starting measurement takes place under standardized conditions. Fasting status, time of day and previously taken products can influence the result; which preparation is needed is clarified by the lab or the doctor’s office. All details are gathered in an overview. For preparing the measurement, the baseline article describes a checklist.

Test (Observation)

In the Test phase, accompanying factors and complaints are recorded: possible side effects (nausea, sleep, stomach), a subjective symptom score from 1 to 10 and gaps in the documentation. If unexpected complaints appear, medical clarification is appropriate, not just the next measurement. For fast-responding markers like ferritin or the omega-3 index, an interim value can be informative. Whether and when to measure is decided by a doctor.

Scale (Evaluation)

In the Scale phase, the follow-up measurement is at the centre, in the same lab, at the same time of day and with the same preparation as the starting measurement so that values stay comparable. The starting and follow-up values are compared. Whether a change is relevant and whether it can be attributed to a product is a medical assessment. From a data-collection point of view, the date and reasoning for each interpretation belong in the documentation.

The KPI Board as an Overview

A KPI board is an overview instrument. Without an overview, the thread is lost after a few weeks. It should show at a glance which lab value is in which phase and what the accompanying data look like. The table shows an example with invented trend values.

Each row is an observation over a period of time. Once the follow-up measurement is available, the entry is updated and dated. In the Lab2go features, products taken can be logged with start and stop dates and compared with one’s own biomarker trends. Lab2go is a tracking tool and gives no recommendation on intake. To understand the biomarkers themselves, the cornerstone guide Understanding Blood Values is worth reading: only once it is clear what a reference range means can trend values be read sensibly.

Example 1: hsCRP Trend

Tobias, 38, sees an hsCRP of 1.8 mg/L in his annual lab work, in the upper normal range. He records the value as his starting point. The interim measurement after six weeks gives 1.4 mg/L, the follow-up measurement after twelve weeks 0.9 mg/L. In parallel, he notes that he takes an omega-3 product.

The trend shows a falling value, but its significance is limited. hsCRP fluctuates from day to day and rises temporarily with infections, for example. Studies examine the relationship between omega-3 intake and inflammation markers, and the evidence is inconsistent. A single observation does not prove a connection. Whether the trend is abnormal or unremarkable and what follows from it is assessed by a doctor.

Example 2: Cortisol Trend

Sabine, 41, has a morning cortisol of 21 µg/dl against a reference range of 5 to 25, which is in the upper part of the range. She records the value at the lab at 7:30 AM and follows it over twelve weeks while taking a plant-based preparation. She documents sleep and well-being with a symptom score of 6 out of 10. The follow-up measurement under identical conditions gives 20 µg/dl, practically no change.

The takeaway: subjective feeling and lab value can diverge. Placebo effects are known for subjective complaints, and morning cortisol depends strongly on time of day, sleep and stress. The evidence on plant-based adaptogens is limited. Without a lab value, the impression of an effect could not have been checked; with one it can, but even then interpretation remains a medical task. For a structured look at product quality, see the Supplement Quality Audit.

My tracking example: I observed my 25-OH-D value over two consecutive periods. What was interesting was that my HRV baseline and sleep score changed in parallel; I had not listed either as something to observe, and without the dashboard I would never have noticed them. A connection is not established by that. What did not work: I had not documented an accompanying product consistently, which limits interpretation. Honest assessment: systematic tracking also exposes your own blind spots.

The 5 Most Common Mistakes in Evaluation

These five patterns show up again and again. Each one makes an observation of little value.

Mistake 1: Too many changes at once. The more products or habits change at the same time, the less can be attributed. If hsCRP falls, it stays unclear whether omega-3, curcumin, resveratrol, vitamin D or something else entirely was involved.

Mistake 2: Patchy documentation. When information is missing, the data are hard to interpret. It is impossible to tell whether a missing effect came from the product or from how it was used.

Mistake 3: No clear reference value. “I take omega-3 for inflammation” is not a question that can be checked. “hsCRP relative to the lab’s reference range” is. Without a concrete number and unit, any evaluation stays vague.

Mistake 4: Wrong measurement points. Measuring ferritin at week 1 makes little sense, as the marker needs 6 to 8 weeks to respond. Measuring 25-OH vitamin D at week 2 is equally unsuitable, with a half-life of around 3 weeks. Measurement points must match the biological response time of the marker, otherwise noise is measured.

Mistake 5: Confounders overlooked. An unchanged result can come from measurement conditions, infections, medication or product quality, for example missing test certificates. These factors are checked before interpretation, not after.

Trend Data and Daily Routines

Observation across several measurement points is the long-term layer. It answers which lab values are followed and which questions arise from them for the conversation with a doctor. Beneath it sits everyday life with recurring habits such as training, sleep and meals. The Cyclic Routine Playbook covers how such routines can be documented. Whether products are paused or changed belongs in consultation with a doctor.

The two layers complement each other: routines provide the context, the measurement series the numbers. Over longer periods, this becomes real long-term biomarker tracking, because several measurement points per year can reveal patterns that a single measurement never would. For 25-OH-D, for instance, a seasonal comparison can be informative, with more detail in the Vitamin D Deficiency Guide.

Conclusion

Statements about supplements are only as reliable as the data behind them. Without a starting value, a reference value and clean documentation, impressions stay impressions. The three phases Audit, Test and Scale are not bureaucracy but a structure for recording lab values traceably and preparing them for the conversation with a doctor. The evidence on many supplements is limited, and personal data replace neither studies nor a medical assessment.

Anyone who keeps their values as a trend has a better basis for the conversation with a doctor. Plans and features of the tracking tool are listed under pricing and plans at Lab2go.

This article is purely informational and does not replace medical advice. Intake, the dose set by a doctor and therapy should be clarified with a doctor. Prescribed medication is not paused without consulting a doctor. For abnormal values, a doctor is the right point of contact.